Physician

Jae H Lee, MD

According to 2025 Medicare claims, Jae Lee, MD (NPI: 1154307080) practices medical oncology in the Eugene-Springfield, OR market, with the plurality of this provider's patient population coming from Lane, OR. This provider's primary affiliated billing organization is ONCOLOGY ASSOCIATES OF OREGON P C (NPI: 1013989854; TIN: 930746296) and primary practice location at 97439-9470. Lee is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Lee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 218 traditional Medicare patients, billed 53,967 HCPCS/CPT codes, and received $458,875 in Medicare payments. The top billing code was 99203 (New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more). Part D data shows 538 prescription claims across 151 beneficiaries totaling $1,987,032 in drug costs, led by Jakafi (Ruxolitinib Phosphate). 2022 DME data shows 11 claims. Open Payments data shows 1 records totaling $1,190. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $684,443 and ending at $458,875. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $726,492 to $1,987,032. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$836K$1.7M2015 Medicare payment: $684,443 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,048,903 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,213,737 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,409,886 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,120,811 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,483,828 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,672,381 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,528,649 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,257,469 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $458,875 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201530869,463$684,443
201638990,427$1,048,903
201742986,082$1,213,737
201842487,589$1,409,886
201940892,748$1,120,811
2020477113,533$1,483,828
2021458121,148$1,672,381
2022470101,289$1,528,649
202341870,601$1,257,469
202421853,967$458,875

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.0M$2.0M2015 Drug cost: $726,492 (USD; Tot_Drug_Cst)2016 Drug cost: $770,562 (USD; Tot_Drug_Cst)2017 Drug cost: $614,619 (USD; Tot_Drug_Cst)2018 Drug cost: $607,867 (USD; Tot_Drug_Cst)2019 Drug cost: $781,695 (USD; Tot_Drug_Cst)2020 Drug cost: $1,759,952 (USD; Tot_Drug_Cst)2021 Drug cost: $2,026,624 (USD; Tot_Drug_Cst)2022 Drug cost: $1,942,956 (USD; Tot_Drug_Cst)2023 Drug cost: $1,931,532 (USD; Tot_Drug_Cst)2024 Drug cost: $1,987,032 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152121,192$726,492
20162181,103$770,562
20172171,198$614,619
20182301,352$607,867
20192271,326$781,695
20202231,460$1,759,952
20212241,406$2,026,624
20222101,159$1,942,956
20231931,009$1,931,532
2024151538$1,987,032

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$16K$32K2015 Medicare payment: $31,960 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $29,514 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $4,329 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $5,050 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $6,392 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $3,610 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $873 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R121$31,960
2016N/R82$29,514
2017N/RN/RN/R
2018N/R50$4,329
2019N/R33$5,050
2020N/R102$6,392
2021N/R50$3,610
2022N/R11$873
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more5656$82
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more136376$65
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more3355$42
36415Insertion of needle into vein for collection of blood sample3360$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count3260$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JakafiRuxolitinib Phosphate25750$435,192
BrukinsaZanubrutinib25750$317,539
CalquenceAcalabrutinib Maleate21630$304,537
LenalidomideLenalidomide13364$192,085
AnastrozoleAnastrozole815,521$1,507

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.0$0N/R
Research PaymentsReported research-related payment or transfer-of-value amount.1$1,190Celgene Corporation
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jae H. Lee, MD?

Tedicare shows public-source Medicare data for Jae H. Lee, MD (NPI 1154307080), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jae H. Lee, MD have ACO affiliation data?

Jae H. Lee, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604) and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Jae H. Lee, MD?

Jae H. Lee, MD is linked to ONCOLOGY ASSOCIATES OF OREGON P C (billing NPI 1013989854) in the available physician profile data.

Does Jae H. Lee, MD have Open Payments data?

Jae H. Lee, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.